Cargando…

Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms

BACKGROUND: Currently, there are no circulating diagnostic biomarkers for gastric neuroendocrine neoplasms (g-NENs). In previous studies, we found that miRNA-202-3p is overexpressed in the tumour tissue of type 1 g-NEN. We speculated that miRNA-202-3p is also likely to be highly expressed in circula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dou, Dou, Li, Xiao-kou, Xia, Qi-sheng, Chen, Ying-ying, Li, Yuan-liang, Wang, Chao, Qi, Zhi-rong, Tan, Huang-ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066967/ https://www.ncbi.nlm.nih.gov/pubmed/33892648 http://dx.doi.org/10.1186/s12876-021-01769-7

Ejemplares similares

Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1
por: Dou, Dou, et al.
Publicado: (2018)

MiRNA Expression in Neuroendocrine Neoplasms of Frequent Localizations
por: Korotaeva, Alexandra, et al.
Publicado: (2021)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
por: Bevere, Michele, et al.
Publicado: (2023)

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms
por: Kidess, Evelyn, et al.
Publicado: (2023)

MiRNA-202-5p promotes Colorectal Carcinogenesis through suppression of PTEN
por: Huang, Jing, et al.
Publicado: (2021)

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021)

Advances in medical treatment for pancreatic neuroendocrine neoplasms
por: Li, Yuan-Liang, et al.
Publicado: (2022)

Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer
por: Zhao, Yu, et al.
Publicado: (2013)

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms
por: Corsello, Andrea, et al.
Publicado: (2018)

Gastric neuroendocrine neoplasms: A review
por: Köseoğlu, Hüseyin, et al.
Publicado: (2021)

New Developments in Gastric Neuroendocrine Neoplasms
por: Exarchou, Klaire, et al.
Publicado: (2022)

Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms
por: Rosiek, Violetta, et al.
Publicado: (2023)

Unusual apocrine carcinoma with neuroendocrine differentiation: a cutaneous neoplasm may be analogous to neuroendocrine carcinoma with apocrine differentiation of breast
por: Li, Yang, et al.
Publicado: (2015)

CT and MR imaging features of mixed neuroendocrine–non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor
por: Zhong, Yanqi, et al.
Publicado: (2023)

Circulating miRNA Biomarkers for Alzheimer's Disease
por: Kumar, Pavan, et al.
Publicado: (2013)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report
por: Fujita, Yasuko, et al.
Publicado: (2019)

Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours
por: Li, Yuan-Liang, et al.
Publicado: (2020)

Gastric neuroendocrine neoplasm with late liver metastasis
por: Marques, Bernardo, et al.
Publicado: (2018)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017)

Circulating miRNAs as biomarkers for severe acute pancreatitis associated with acute lung injury
por: Lu, Xiao-Guang, et al.
Publicado: (2017)

Maternal Circulating Exosomal miRNAs as Non-invasive Biomarkers for the Prediction of Fetal Ventricular Septal Defect
por: Jin, Yuxia, et al.
Publicado: (2021)

Marital status, an independent predictor for survival of gastric neuroendocrine neoplasm patients: a SEER database analysis
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms
por: Zhang, Sheng, et al.
Publicado: (2019)

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms
por: Koenig, Alexander, et al.
Publicado: (2017)

Cell-free Circulating miRNA Biomarkers in Cancer
por: Mo, Meng-Hsuan, et al.
Publicado: (2012)

Methodological challenges in utilizing miRNAs as circulating biomarkers
por: Moldovan, Leni, et al.
Publicado: (2014)

Challenges in Using Circulating miRNAs as Cancer Biomarkers
por: Tiberio, Paola, et al.
Publicado: (2015)

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018)

Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms
por: Iwasaki, Kenichi, et al.
Publicado: (2022)

Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasm
por: Yang, Zhi-hao, et al.
Publicado: (2023)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Mixed Neuroendocrine Non-Neuroendocrine Neoplasm Arising in the Ectopic Gastric Mucosa of Esophagus
por: Gushima, Ryosuke, et al.
Publicado: (2022)

Circulating miRNA signature for early diagnosis of lung cancer
por: Lin, Pei-Ying, et al.
Publicado: (2011)

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
por: Cavalcoli, Federica, et al.
Publicado: (2023)

Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis
por: Duttagupta, Radha, et al.
Publicado: (2012)

Circulating miRNAs as Potential Biomarkers for Celiac Disease Development
por: Tan, Ineke L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eohda02o3s84l32pu5di142q36